
04 Nov 2021
Hikma Pharmaceuticals: FY21 on track, pipeline strengthens further
This content is only available within our institutional offering.

Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
Hikma Pharmaceuticals: FY21 on track, pipeline strengthens further
Hikma Pharmaceuticals Plc (HIK:LON) | 1,786 -536 (-1.7%) | Mkt Cap: 3,964m
- Published:
04 Nov 2021 -
Author:
Stefan Hamill | Paul Cuddon | Kane Slutzkin -
Pages:
4 -